Should Angiotensin-Converting Enzyme Inhibitors Be Added To The Water Supply Of Patients With Diabetes?-Reference-Cited by-同舟云学术

Should Angiotensin-Converting Enzyme Inhibitors Be Added To The Water Supply Of Patients With Diabetes?

Published:2001-01 Issue:1 Volume:7 Page:59-63
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Bell David S.H.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://aace.metapress.com/index/NEYQ7EFK0CFFCPHL.pdf

Reference40 articles.

1. (Heart Outcomes Prevention Evaluation Study Investigators). Effects of an angiotensin-convert-ing-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published errata appear in N Engl J Med. 2000;342:748 and 2000;342:1376];Yusuf;N Engl J Med,2000

2. (Collaborative Study Group). The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy [published erratum appears in N Engl J Med. 1993;330:152];Lewis;N Engl J Med,1993

3. Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy;Mimran;J Hypertens,1988

4. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy;Bjorck;Br Med J (Clin Res Ed),1986

5. Current strategies for retarding progression of renal disease;Mackenzie;Am J Kidney Dis,1998

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential effect of ?-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI;Diabetic Medicine;2007-07

2. Drugs for cardiovascular risk reduction in the diabetic patient;Current Diabetes Reports;2001-06